CervoMed Inc.(CRVO)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

CervoMed Inc. (CRVO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CRVO at 3.9/100 on a 32-signal composite quality model, placing it at rank #2,956 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of CRVO by reported 13-F value include Woodline Partners, VANGUARD CAPITAL MANAGEMENT, SABBY MANAGEMENT, based on the most recent SEC filings. CRVO trades on the Nasdaq exchange and files with the SEC under CIK 1053691. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CRVO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CervoMed Inc. directly from SEC EDGAR.

AI Quality Score

3.9/100

AI Rank

#2,956

Revenue

$0.00

Net Income

$-6.6M

CRVO key financials by period

CervoMed Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$4.0M$-27.0M—
FY 202410-K$9.7M$-16.3M-187.2%
FY 202310-K$7.1M$-2.2M-109.3%
FY 201310-K$71.7K$-2.5M—
FY 201210-K/A$374.5K$-6.9M—
FY 201110-K/A$570.5K$-22.6M—

Institutions holding CRVO

Institutional investors reporting a position in CervoMed Inc. on SEC Form 13F.
InstitutionSharesValueReported
Woodline Partners688,987$2.1M2026-06-30
VANGUARD CAPITAL MANAGEMENT316,202$980.2K2026-06-30
SABBY MANAGEMENT248,880$771.5K2026-06-30
GEODE CAPITAL MANAGEMENT66,923$207.5K2026-06-30
BlackRock53,845$166.9K2026-06-30
Byrne Asset Management51,250$158.9K2026-06-30
CITIZENS FINANCIAL GROUP37,477$116.2K2026-06-30
VANGUARD FIDUCIARY36,151$112.1K2026-06-30
JANE STREET GROUP32,231$99.9K2026-06-30
THOMPSON DAVIS29,750$92.2K2026-06-30
SEC EDGAR: CIK 1053691 →
CRVO

CervoMed Inc.

CRVO
NasdaqSmall CapHealthcare

13F Pro Quality Score

3.9/100

Rank #2,956 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$0

Net Income

Q2 2026
EDGAR

$-6.57M

EPS (Diluted)

Q2 2026
EDGAR

$-0.64

Top Institutional Holders

as of Q2 2026
$5.42M total
Woodline Partners LP
$2.14MNew
VANGUARD CAPITAL MANAGEMENT LLC
$980.2K0.0%
SABBY MANAGEMENT, LLC
$771.5KNew
GEODE CAPITAL MANAGEMENT, LLC
$207.5K-10.0%
BlackRock, Inc.
$166.9K+4.2%
Byrne Asset Management LLC
$158.9K+248.6%
CITIZENS FINANCIAL GROUP INC/RI
$116.2K0.0%
VANGUARD FIDUCIARY TRUST CO
$112.1K0.0%
JANE STREET GROUP, LLC
$99.9K+76.6%
THOMPSON DAVIS & CO., INC.
$92.2K+197.5%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…